Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 14/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 14/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 14/20 | 0.52 |
| ▸ | GPR39 | O43194 | 1/20 | 0.43 |
| ▸ | VNN1 | O95497 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28247582 | 0.84 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2GPR39 | |
| SCHEMBL28247670 | 0.83 | HDAC6 (0.57) | HDAC6HDAC3HDAC1HDAC2GPR39 | |
| SCHEMBL28247580 | 0.83 | HDAC6 (0.49) | HDAC6HDAC3HDAC1HDAC2GPR39 | |
| SCHEMBL28247585 | 0.83 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2GPR39 | |
| SCHEMBL28248162 | 0.81 | HDAC6 (0.60) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28248254 | 0.80 | HDAC6 (0.55) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28248331 | 0.79 | HDAC6 (0.61) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL24968632 | 0.79 | HDAC6 (0.62) | HDAC6HDAC3HDAC1HDAC2VNN1 | |
| SCHEMBL28248165 | 0.77 | HDAC6 (0.44) | HDAC6HDAC3HDAC1HDAC2GPR39 | |
| SCHEMBL28865489 | 0.76 | HDAC3 (0.55) | HDAC6HDAC3HDAC1HDAC2GPR39 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108699048-A | Oxadiazolamide derivative compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same | 株式会社钟根堂 | 2018-10-23 | — | — | CN | disclosed |